Cognition Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Cognition Therapeutics Total Assets Growth & History (CGTX)
Cognition Therapeutics's total assets was $48.4M for fiscal 2025.
View full Cognition Therapeutics company overviewCognition Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $48.4M | $18.2M | +60.05% |
| 2024 | 2024-12-31 | $30.2M | −$4.9M | −14.02% |
| 2023 | 2023-12-31 | $35.2M | −$15.3M | −30.27% |
| 2022 | 2022-12-31 | $50.4M | −$8.7M | −14.73% |
| 2021 | 2021-12-31 | $59.1M | $52.0M | +730.69% |
| 2020 | 2020-12-31 | $7.1M | — | — |
Cognition Therapeutics quarterly total assets
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $38.9M | $19.3M | +98.23% |
| Q1 2026 | 2026-03-31 | $36.1M | $12.6M | +53.79% |
| Q4 2025 | 2025-12-31 | $48.4M | $18.2M | +60.05% |
| Q3 2025 | 2025-09-30 | $43.4M | $15.8M | +57.35% |
| Q2 2025 | 2025-06-30 | $19.6M | −$14.7M | −42.91% |
| Q1 2025 | 2025-03-31 | $23.5M | −$15.4M | −39.51% |
| Q4 2024 | 2024-12-31 | $30.2M | −$4.9M | −14.02% |
| Q3 2024 | 2024-09-30 | $27.6M | −$11.2M | −28.87% |
| Q2 2024 | 2024-06-30 | $34.4M | −$9.6M | −21.82% |
| Q1 2024 | 2024-03-31 | $38.9M | −$6.8M | −14.92% |
| Q4 2023 | 2023-12-31 | $35.2M | −$15.3M | −30.27% |
| Q3 2023 | 2023-09-30 | $38.8M | −$14.8M | −27.61% |
| Q2 2023 | 2023-06-30 | $44.0M | −$8.9M | −16.76% |
| Q1 2023 | 2023-03-31 | $45.7M | −$13.0M | −22.20% |
| Q4 2022 | 2022-12-31 | $50.4M | −$8.7M | −14.73% |
| Q3 2022 | 2022-09-30 | $53.6M | $40.2M | +300.01% |
| Q2 2022 | 2022-06-30 | $52.8M | — | — |
| Q1 2022 | 2022-03-31 | $58.7M | — | — |
| Q4 2021 | 2021-12-31 | $59.1M | $52.0M | +730.69% |
| Q3 2021 | 2021-09-30 | $13.4M | — | — |
| Q4 2020 | 2020-12-31 | $7.1M | — | — |
Cognition Therapeutics total assets trends
Over the last five fiscal years, Cognition Therapeutics's total assets increased from $7.1M to $48.4M, a change of $41.3M. The latest reported quarter, Q2 2026, shows $38.9M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cognition Therapeutics source filings ↗